drugset / Trial / NCT03861390

Woodsmoke Particulate + Prednisone

NCT03861390 ↗

RandomizedCrossoverTriple-blindTreatment

Summary

Deployment of military personnel has been associated with increased respiratory illness likely due, in part, to inhalation of unusual particulate matter (PM), such as from burn pits. Inflammation is a key initial response to inhaled particulates. The researchers have developed a protocol using inhaled wood smoke particles (WSP) as a way to study PM-induced airway inflammation. Exposure to wood smoke particles causes symptoms, even in healthy people, such as eye irritation, cough, shortness of breath, and increased mucous production. The purpose of this research study is to see if an oral steroid treatment can reduce the airway inflammation caused by the inhaled WSP. The exposure will be 500 µg/m³ of WSP for 2 hours, with intermittent exercise on a bicycle and rest. The wood is burned in a typical wood stove and piped into the chamber.

Timeline

Start
2019-03-22
Primary completion
2023-05-12
Completion
2023-05-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisone Other / unclassified 60 mg Oral